Cargando…
What, When and How to Measure—Peripheral Biomarkers in Therapy of Huntington’s Disease
Among the main challenges in further advancing therapeutic strategies for Huntington’s disease (HD) is the development of biomarkers which must be applied to assess the efficiency of the treatment. HD is a dreadful neurodegenerative disorder which has its source of pathogenesis in the central nervou...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913877/ https://www.ncbi.nlm.nih.gov/pubmed/33557131 http://dx.doi.org/10.3390/ijms22041561 |